Ligand validation:4CPZ

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4CPZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4CPZ_NAG_D_1470	62%	75%	0.121	0.911	0.47	0.5	-	-	0	0	100%	0.9333
4CPZ_NAG_A_1470	48%	80%	0.18	0.923	0.37	0.47	-	-	0	0	100%	0.9333
4CPZ_NAG_G_1470	40%	72%	0.163	0.873	0.4	0.67	-	1	0	0	100%	0.9333
4CPZ_NAG_C_1469	27%	86%	0.209	0.857	0.27	0.44	-	-	0	0	100%	0.9333
4CPZ_NAG_B_1470	12%	69%	0.283	0.814	0.65	0.53	-	-	0	0	100%	0.9333
4CPZ_NAG_E_1470	12%	79%	0.332	0.86	0.44	0.43	-	-	0	0	100%	0.9333
4CPZ_NAG_H_1469	2%	75%	0.433	0.742	0.5	0.49	-	-	0	0	100%	0.9333
1INV_NAG_A_467	61%	24%	0.094	0.88	1.71	1.42	3	3	0	0	100%	0.7027
1IVB_NAG_A_467	45%	5%	0.12	0.848	3.14	2.37	3	6	1	0	100%	0.9333
3K38_NAG_A_900	42%	29%	0.162	0.88	0.77	2.03	-	2	0	0	100%	0.9333
1B9V_NAG_A_467	34%	35%	0.153	0.848	1.33	1.24	2	3	2	0	93%	0.9333
1B9T_NAG_A_467	31%	31%	0.205	0.888	1.35	1.38	2	3	3	0	93%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.